Kidney Cancer Clinical Trials

Clinical trial focusing on vandetanib and kidney cancer. Phase II Study of Vandetanib in Individuals With Kidney Cancer

Clinical trial focusing on surgery after sunitinib malate in metastatic kidney cancer patients. Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME)

Clinical trial focusing on Serum CA9 level and metastatic renal cell cancer. Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer (CA9CRM)

Clinical trial focusing on Autologous Dendritic Cell Immunotherapy and Advanced Renal Cell Carcinoma. Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC) (ADAPT)

Clinical trial focusing on Interleukin 2 and kidney cancer. Interleukin-2 in Metastatic Kidney Cancer

A look at the following clinical trial: VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer

A look at the following clinical trial: Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

A look at the following clinical trial: MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer

A look at the following clinical trial: Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer (CMM)

A look at the following clinical trial: Dalteparin in Combination With Sunitinib in Patients With Metastatic Kidney Cancer